RTRAF pseudogene 1 (RTRAFP1)

**RTRAF pseudogene 1 (RTRAFP1)** is classified as a *pseudogene*, meaning it is a genomic sequence similar to the protein-coding "RNA transcription, translation and transport factor" (RTRAF) gene but with mutations that prevent it from encoding a functional protein[1][2][4][5]. Pseudogenes can sometimes be transcribed into RNA and take on regulatory roles as non-coding RNAs, potentially by sponging microRNAs or modulating gene expression, but there is no published functional data for RTRAFP1 specifically[1][2][5]. Most pseudogenes, including RTRAFP1, are not considered druggable or bona fide therapeutic targets, and there is no established clinical relevance, biomarker status, or direct involvement in disease for this particular pseudogene[1][2][5][4]. **Notes on correctness:** - *Is_incorrect* is marked **true** because **pseudogenes are not considered therapeutic targets** (such as receptors, enzymes, transporters, etc.), and there is no evidence that RTRAFP1 is incorrectly named, but it is not an actionable target for drug development[2][4][1]. - There are no known drugs, mechanism of action, or biomarker roles specific to RTRAFP1. - Most databases and literature sources on human gene targets either do not mention this pseudogene or only list it among "non-coding" elements[1][2][5]. **Summary**: RTRAF pseudogene 1 (RTRAFP1) is a non-protein-coding pseudogene, not a valid or recognized therapeutic target, with no established biological or disease role, drug interactions, or biomarker utility[1][2][5][4].

Other names

RTRAFP1RNA transcription, translation and transport factor pseudogene 1